SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939767-22-000016
Filing Date
2022-02-17
Accepted
2022-02-17 16:20:50
Documents
15
Period of Report
2022-02-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20220217.htm   iXBRL 8-K 35223
2 EX-99.1 exel20211231exhibit991.htm EX-99.1 169763
6 exel-20220217_g1.jpg GRAPHIC 116418
7 exellogo18q3a20.jpg GRAPHIC 116418
  Complete submission text file 0000939767-22-000016.txt   780076

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20220217.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20220217_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20220217_pre.xml EX-101.PRE 12520
9 EXTRACTED XBRL INSTANCE DOCUMENT exel-20220217_htm.xml XML 10687
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 22648378
SIC: 2836 Biological Products, (No Diagnostic Substances)